Nanotech bill sails through House
This article was originally published in The Tan Sheet
Executive Summary
The House Feb. 11 passes the National Nanotechnology Initiative Amendments Act, H.R. 554, to direct federal nanotechnology research, strengthen public-private partnerships through industry liaison groups and prioritize protecting public health and safety. An identical version of the bill cleared the House in 2008, but failed in the Senate (1"The Tan Sheet" Feb. 2, 2009, p. 16). In a same-day release, bill sponsor and Science and Technology Committee Chairman Bart Gordon says the legislation "will reduce the current uncertainty that inhibits commercial development of nanotechnology and will provide a sound basis for future rulemaking." The Tennessee Democrat adds that nanotechnology could be a $2.6 trillion industry by 2014
You may also be interested in...
House Shows Nanotech Safety Interest With Bill To Sharpen Federal Plan
The House Committee on Science and Technology will consider legislation crafted to provide strategic direction to the federal research program for nanotechnology
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.